ArticleOncotarget2015

Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.

Ulises D Orlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.